Loader

Pathways

PathWhiz ID Pathway Meta Data

PW132360

Pw132360 View Pathway
metabolic

Tinidazole Drug Metabolism

Homo sapiens
Tinidazole is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Tinidazole passes through the liver and is then excreted from the body mainly through the kidney.

PW145012

Pw145012 View Pathway
drug action

Tinidazole Drug Metabolism Action Pathway

Homo sapiens

PW127758

Pw127758 View Pathway
drug action

Tinzaparin Action Pathway

Homo sapiens
Tinzaparin is a low molecular weight heparin (LMWH), it is an anticoagulant that halts the formation of thrombi. It binds to antithrombin III forming a complex that speeds up the inhibition of factor Xa. This stops the generation of thrombin and the coagulation cascade, it is administered via subcutaneous injection. Through the liver, it is metabolized through sulfation and polymerization and is eliminated through the kidneys. There is some risk of osteoporosis with increasing duration of use, bleeding, alopecia, and heparin-induced thrombocytopenia (HIT). It can interact with herbs and supplements, so avoid those with anticoagulants and antiplatelet activity such as garlic, ginger, bilberry, danshen, piracetam and ginkgo bilba.

PW145822

Pw145822 View Pathway
drug action

Tinzaparin Drug Metabolism Action Pathway

Homo sapiens

PW126993

Pw126993 View Pathway
drug action

Tioconazole Action Pathway

Homo sapiens
Tioconazole is an imidazole antifungal drug used primarily for vulvovaginal candidiasis (vaginal yeast infection), but it can be used for skin infections such as ringworm, jock itch, athlete's foot, and tinea versicolor or "sun fungus". Tioconazole is applied topically to the infected area then absorbed into the infected cell to target the fungal cells. It can also be taken orally. Terconazole inhibits lanosterol 14-alpha demethylase in the endoplasmic reticulum of fungal cells. Lanosterol 14-alpha demethylase is the enzyme that catalyzes the synthesis of 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol from lanosterol. With this enzyme inhibited ergosterol synthesis cannot occur which causes a significant low concentration of ergosterol in the fungal cell. Ergosterol is essential in maintaining membrane integrity in fungi. Without ergosterol, the fungus cell cannot synthesize membranes thereby increasing fluidity and preventing growth of new cells. This leads to cell lysis which causes it to collapse and die. Through unknown mechanisms, tioconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel.

PW145105

Pw145105 View Pathway
drug action

Tioconazole Drug Metabolism Action Pathway

Homo sapiens

PW176237

Pw176237 View Pathway
metabolic

Tioconazole Predicted Metabolism Pathway

Homo sapiens
Metabolites of Tioconazole are predicted with biotransformer.

PW128259

Pw128259 View Pathway
drug action

Tioguanine Action Pathway

Homo sapiens
Tioguanine is an antineoplastic agent from the purine analog class. This drug also has antimetabolite action. Tioguanine is indicated for remission induction and remission consolidation in the treatment of acute nonlymphocytic leukemias. When this drug enters the cells, it competes with hypoxanthine and guanine for the hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) and is itself converted to 6-thioguanilyic acid (TGMP), which reaches high intracellular concentrations at therapeutic doses. TGMP is a cytotoxic agent, it will interfere with the synthesis of guanine nucleotides by inhibiting the glutamine-5-phosphoribosylpyrophosphate aminotransferase (de novo pathway of purine ribonucleotide synthesis) enzyme by pseudofeedback. Furthermore, TGMP also inhibits the conversion of inosinic acid (IMP) to xanthylic acid (XMP) by competition for the enzyme IMP dehydrogenase. Thioguanine nucleotides are incorporated into both the DNA and the RNA. The final result is the sequential blockade of the usage and synthesis of purines, leading to apoptosis in the S phase of the cell cycle. This drug is administered as an oral tablet. An overdose of tioguanine may result in symptoms like nausea, vomiting, malaise, hypotension, and diaphoresis.

PW145823

Pw145823 View Pathway
drug action

Tiopronin Drug Metabolism Action Pathway

Homo sapiens

PW145418

Pw145418 View Pathway
drug action

Tiotropium Drug Metabolism Action Pathway

Homo sapiens